Abstract
Although it is largely unknown how diet might modulate rheumatoid arthritis (RA), dietary interventions, including so-called “low-carbohydrate” diets, may be considered for RA patients because of the high incidence of cardiovascular comorbidity. However, it has been shown that restriction or skewed intake of particular nutrient may alter the components of the intestinal flora. Changes to the gut microbiota or dysbiosis may be relevant to the pathogenesis of RA because the gut microbiota is reported to regulate the T cell phenotype and T cell-mediated immunity. RA patients should be advised that a balanced diet that includes appropriate amounts of carbohydrate, especially dietary fiber, is important for maintaining the symbiosis of intestinal flora, which could be beneficial for preventing autoimmunity. The review attempts to focus current findings regarding the suggested relationship between diet-derived carbohydrate, gut microbiota, and the pathogenesis of RA.
Introduction
There has been a long-standing debate, which has continued even since the development of remission-inducible disease-modifying anti-rheumatic drugs (DMARDs), over whether diet plays a pathogenic or a disease-modulating role in autoimmune diseases including rheumatoid arthritis (RA) (1, 2). Various dietary patterns, such as Mediterranean-style or vegetarian diets, as well as nutritional factors including polyphenols and omega-3 polyunsaturated fatty acids are speculated to be relevant to the occurrence and/or outcome of the disease. However, none of these diet or nutrients has been established so far as bringing substantial benefit with a clinically proven disease-modifying effect (3, 4).
On the other hand, studies have shown that the risk of metabolic syndrome is higher in RA patients than in healthy subjects (5). Further, RA patients may be in condition so-called “rheumatoid cachexia,” that is, they would have an accumulation of adipose tissue besides decrease of muscle (i.e., sarcopenia) due to catabolic change and decreased physical activity (5, 6). Such metabolic imbalance in RA is caused by chronic inflammation with elevated levels of wasting cytokines including tumor necrosis factor (TNF)-α, therefore potent anti-rheumatic therapy using DMARDs may improve the imbalance at least to some extent (6, 7). Nevertheless, even if the inflammation would be controlled by the medication, appropriate nutritional intervention should still be considered for these patients, who may have a skewed nutritional intake and insufficient quality of diet (8). In fact, we have observed that some RA patients have difficulty in cooking and/or eating because of their arthritic symptoms, and that the limitations in their joint movement may affect their dietary intake (9).
Omega-3 PUFAs (such as eicosapentaenoic acid and docosahexaenoic acid) have been reported to exert an anti-inflammatory effect through intra-nuclear signals that suppress inflammatory signals via peroxidase proliferator activator receptors (10). As for RA, there are studies that showed the efficacy of omega-3 PUFAs or fish oil (as a source of omega-3 PUFA) for reducing RA-related disease activity markers, while improving the blood lipid profile [reviewed in (11)]. Nevertheless, statistical significance of these experiments in which PUFAs were administered to RA patients are not essentially robust because of its sample size and/or clinical setting, as there are also reports with negative results (12, 13); instead, long-term administration of relatively high dose of PUFA in RA patients might cause adverse events such as critical hemorrhage (14). Solid clinical evidence should be obtained from large-scale, placebo-controlled double-blinded clinical trials, although this may be difficult to achieve, because the clinical background and dietary habit differ among patients.
Of note, from a nutritional view, excess consumption of any oil or fat will also increase total energy intake (i.e., the total number of calories consumed each day). As diet does not involve only the serial ingestion of a single nutrient, the relative proportions of protein, fat, and carbohydrate intake may also alter that individual's overall health outcome, including the immunological responses (15).
Gut microbiota modulate immunity
From the oral cavity to the rectum, the gastrointestinal tract can be exposed to extrinsic pathogens. The largest immune system in the body, the gut-associated lymphatic tissue, has evolved in the gut mucosa under the coexistence of microbiota on the gut surface to protect the body from pathogenic attack (16). This tissue includes Peyer's patches in the small intestine and mesenteric lymph nodes, which trigger immune responses against antigens that enter the intestine.
Around 100 trillion bacteria are thought to be living in the human gastrointestinal tract, and the composition of the bacteria (“gut microbiome”) varies under influence of many factors including diet, medication, smoking or stress (17, 18).
The commensal gut bacteria have an important impact to individual's immune responses, both of innate and adoptive systems. For the initial defense against gut epithelium-invading pathogen, pattern-recognition receptors including toll-like receptors (TLRs) recognize microorganism-associated molecular patterns (MAMP) like flagellin and lipopolysaccharide (LPS). Intracellular signals via TLRs, e.g., TLR4 expressed in intestinal epithelial cells, would then lead to expression of pro- or anti-inflammatory cytokines. Indigenous microbiota of gram-positive rods, Clostridia and Bifidobacteria for example, regulate immunity by distinct responses; Clostridium difficile was reported to recruit neutrophils to the infected sites to promote inflammation, while Bifidobacterium infantis suppresses inflammation by inducing anti-inflammatory cytokines like interleukin (IL)-10 from dendritic cells (18).
Gut bacteria can also regulate T cell differentiation, thereby modulating adoptive immunity. For instance, Clostridia were found to induce expression of transforming growth factor (TGF)-β, which would lead to regulatory T cell (Treg) differentiation to maintain homeostasis of gut environment (19–21). The anti-inflammatory effect of Clostridia was supported by an experiment in which oral administration of the bacteria attenuated experimental colitis with a shift of T cells to anti-inflammatory subset (20).
Nutrients, in particular dietary fiber, is an important regulator of the gut microbiome (18, 21, 22). During fermentation of dietary fiber, gut bacteria release short-chain fatty acids (SCFAs) (including acetate, butyrate, and propionate), which synergistically act to facilitate gut homeostasis with the dietary fiber (21). For example, besides the promotion of Treg cell responses, SCFAs are known to reduce expression of inflammatory chemokines or cytokines such as TNF-α, IL-6, and interferon-gamma (21).
Gut microbiota and RA
The potential implication of gut or oral microbiome in rheumatic diseases had been a debate for a long time, and recent development of experimental technology, for example, sequencing, analysis of molecular markers, and the “omics” methodologies has greatly advanced the knowledge [reviewed in (23)].
Accumulating studies demonstrated that gut microbiome of RA patients have distinct gut microbiota compared to control diseases or healthy subjects. Although the unique microbiome might be a secondary effect to the disease and may not necessarily reflect causal relationship (24), studies obtained from early stage or DMARDs-naïve RA patients seem to reflect more disease-related microbiome. In this regard, an imbalance of Prevotella species in intestinal microbiome have been found in studies with early-stage RA patients (23, 25, 26). Although its pathological role has not been understood, further investigation will clarify how the biased microbiome would contribute to the pathophysiology of RA. Interestingly, abundant presence of Prevotella has been suggested to correlate with a presence of “shared-epitope” genotype in RA, implying that potential contribution of a particular human leukocyte antigen (HLA) genotype in the formation of unique microbiome and also in the susceptibility of autoimmune disease (23).
As RA is an autoimmune disease, it can be speculated that there would be molecular similarity between bacterial component(s) and potential autoantigen(s) (i.e., “molecular mimicry”), and that T cell recognition of the bacterial component might trigger the pathogenic autoimmunity [reviewed in (27)].
Using a metagenomic survey, Zhang et al. (28) reported that gut samples from RA patients were enriched in Gram-positive bacteria and depleted of Gram-negative bacteria; and demonstrated an existence of molecular mimicry between RA-associated antigens (e.g., collagen XI, HLA-DRB1) and microbial genes (e.g., from Clostridia) identified in gut and oral samples from RA patients. Further, Pianta et al. (29) demonstrated a sequence homology between two newly identified RA-specific autoantigens (N-acetylglucosamine-6-sulfatase and filamin A) and gut bacteria (Prevotella species), demonstrating cross-reactivity to the microbial peptides by T cells from RA patients.
“Diet and RA”: the balance determines
A recent paper by Hu et al. reported an interesting correlation between diet and RA (30). The authors evaluated the association between long-term dietary quality, measured according to the 2010 Alternative Healthy Eating Index (AHEI-2010), and the incidence of RA. The AHEI-2010 scores dietary quality based on an individual's intake of “healthy” foods (such as fruit, vegetables, whole grains, nuts, omega-3 fatty acids, PUFAs, and moderate alcohol consumption) and “unhealthy” items (including sugar-sweetened beverages, red and processed meat, trans fats, and sodium). Higher scores were positively associated with a “desirable lifestyle,” with reduced risk for chronic diseases such as cardiovascular diseases and type 2 diabetes. The study found that women with higher AHEI-2010 scores had a lower risk of developing RA. More specifically, women with scores in the top quartile had a 33% lower risk of RA compared to those with scores in the lowest quartile. Based on the finding, the authors concluded “an overall healthy diet quality may be more beneficial for RA risk reduction than individual foods and nutrients, particularly for early-onset seropositive RA” (30). Although the mechanisms underlying this protection have not been determined, it may result from a higher intake of antioxidants and dietary fiber (30). Indeed, intake of dietary fiber has been reported to ameliorate inflammation (31), whereas its deficiency enhances inflammation through degradation of mucosal barrier of intestine (32).
It has been reported that enterotypes (clusters of a relatively stable gut microbiome) may be determined or influenced by long-term dietary patterns (33, 34). dominance of Prevotella and Bacteroides species could be associated with dietary intake: a higher intake of animal protein and saturated fat would be associated with a dominance of Bacteroides, whereas a higher carbohydrate intake would favor Prevotella dominance (33). As previously mentioned, Prevotella is one of the candidate pathogenic bacteria for human RA. If so, a higher carbohydrate intake may lead to alteration of gut microbiome such that Prevotella species dominate, thereby increasing susceptibility to RA. In turn, the reported efficacy of omega-3 fatty acids against RA may partly depend on the suppression of Prevotella-induced inflammation (35).
Patients with RA may exhibit increased resting energy expenditure because of chronic inflammation, and the inflammation-induced metabolic imbalance would lead to rheumatoid cachexia (6). On the other hand, insufficient relative intake in carbohydrate intake leads to an excessive intake of fat and protein, which may result in the further deterioration of cardiovascular risks as well as in renal complications. Taken together, RA patients should be recommended not to consume excessive amounts of energy (i.e., calories) and carbohydrate, but they should nevertheless consume sufficient diet, including an appropriate amount of dietary fiber, to secure intake of appropriate energy and to maintain gut homeostasis (Figure 1).
Figure 1
Concluding remarks
Along with smoking or stress, diet is one of the modifiable environmental factors for the onset and/or disease outcome of RA (36). Through improving metabolic imbalance, and via modulation of the gut microbiota, diet may gradually adjust the physiological condition as well as immunological response in RA patients.
A balanced intake of a variety of foodstuff including dietary fiber is important for maintaining diverse intestinal flora, and for reducing metabolic and inflammatory risks. Long-term restriction of a single nutrient may not be advisable and should only be done under careful observation by nutritional experts.
Statements
Author contributions
KM conceived of the article, wrote, revised and approved the whole manuscript.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
DahanSSegalYShoenfeldY. Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?Nat Rev Rheumatol. (2017) 13:348–58. 10.1038/nrrheum.2017.42
2.
BadshaH. Role of diet in influencing rheumatoid arthritis disease activity. Open Rheumatol J. (2018) 12:19–28. 10.2174/1874312901812010019
3.
HagenKBByfuglienMGFalzonLOlsenSU. Smedslund G. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. (2009) 21:CD006400. 10.1002/14651858.CD006400.pub2
4.
HuYCostenbaderKHGaoXHuFBKarlsonEWLuB. Mediterranean diet and incidence of rheumatoid arthritis in women. Arthritis Care Res. (2015) 67:597–606. 10.1002/acr.22481
5.
KerekesGNurmohamedMTGonzalez-GayMASeresIParaghGKardosZ. Rheumatoid arthritis and metabolic syndrome. Nat Rev Rheumatol. (2014) 10:691–6. 10.1038/nrrheum.2014.121
6.
MasukoK. Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr. (2014) 1:20. 10.3389/fnut.2014.00020
7.
ChenDYChenYMHsiehTYHsiehCWLinCCLanJL. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res. Ther. (2015) 17:52. 10.1186/s13075-015-0559-8
8.
BerubeLTKielyMYaziciYWoolfK. Diet quality of individuals with rheumatoid arthritis using the Healthy Eating Index (HEI)-2010. Nutr Health (2017) 23:17–24. 10.1177/0260106016688223
9.
MizukamiYMatsuiTTohmaSMasukoK. Distinct patterns of dietary intake in different functional classes of patients with rheumatoid arthritis. Top Clin Nutr. (2017) 32:141–51. 10.1097/TIN.0000000000000099
10.
MasukoK. Contribution of dietary factors to peroxisome proliferator-activated receptor-mediated inflammatory signaling in arthritic diseases. Curr Rheumatol Rev. (2012) 8:134–40. 10.2174/157339712802083803
11.
GioxariAKalioraACMarantidouFPanagiotakosDP. Intake of omega-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a systematic review and meta-analysis. Nutrition (2018) 45:114–24.e4. 10.1016/j.nut.2017.06.023
12.
ParkYLeeAShimSCLeeJHChoeJYAhnH. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. J Nutr Biochem. (2013) 24:1367–72. 10.1016/j.jnutbio.2012.11.004
13.
KhorsanRCrawfordCIvesJAWalterARJonasWB. The effect of omega-3 fatty acids on biomarkers of inflammation: a rapid evidence assessment of the literature. Mil Med. (2014) 179:2–60. 10.7205/MILMED-D-14-00339
14.
ProudmanSMJamesMJSpargoLDMetcalfRGSullivanTRRischmuellerMet al. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann. Rheum. Dis. (2015) 74:89-95. 10.1136/annrheumdis-2013-204145
15.
OguraMOguraHIkeharaSGoodRA. Influence of dietary energy restriction on the numbers and proportions of Ly-1+ B lymphocytes in autoimmunity-prone mice. Proc Natl Acad Sci USA. (1989) 86:4225–9. 10.1073/pnas.86.11.4225
16.
HooperLVLittmanDRMacphersonAJ. Interactions between the microbiota and the immune system. Science (2012) 336:1268–73. 10.1126/science.1223490
17.
Van de WieleTVan PraetJTMarzoratiMDrennanMBElewautD. How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol. (2016) 12:398–411. 10.1038/nrrheum.2016.85
18.
MaNGuoPZhangJHeTKimSWZhangGet al. Nutrients mediate intestinal bacteria-mucosal immune crosstalk. Front Immunol. (2018) 9:5. 10.3389/fimmu.2018.00005
19.
AtarashiKTanoueTShimaTImaokaAKuwaharaTMomoseYet al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2011) 331:337–41. 10.1126/science.1198469
20.
AtarashiKTanoueTOshimaKSudaWNaganoYNishikawaHet al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature (2013) 500:232–6. 10.1038/nature12331
21.
ThorburnANMaciaLMackayCR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity (2014) 40:833–42. 10.1016/j.immuni.2014.05.014
22.
DaienCIPingetGVTanJKMaciaL. Detrimental impact of microbiota-accessible carbohydrate-deprived diet on gut and immune homeostasis: an overview. Front Immunol. (2017) 8:548. 10.3389/fimmu.2017.00548
23.
ScherJULittmanDRAbramsonSB. Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheumatol. (2016) 68:35–45. 10.1002/art.39259
24.
BruscaSBAbramsonSBScherJU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol. (2014) 26:101–7. 10.1097/BOR.0000000000000008
25.
MaedaYKurakawaTUmemotoEMotookaDItoYGotohKet al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. (2016) 68:2646–61. 10.1002/art.39783
26.
VaahtovuoJMunukkaEKorkeamakiMLuukkainenRToivanenP. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. (2008) 35:1500–5.
27.
LeeNKimWU. Microbiota in T-cell homeostasis and inflammatory diseases. Exp Mol Med. (2017) 49:e340. 10.1038/emm.2017.36
28.
ZhangXZhangDJiaHFengQWangDLiangDet al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. (2015) 21:895–905. 10.1038/nm.3914
29.
PiantaAArvikarSLStrleKDrouinEEWangQCostelloCEet al. Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints. J Clin Invest. (2017) 127:2946–56. 10.1172/JCI93450
30.
HuYSparksJAMalspeisSCostenbaderKHHuFBKarlsonEWet al. Long-term dietary quality and risk of developing rheumatoid arthritis in women. Ann Rheum Dis. (2017) 76:1357–64. 10.1136/annrheumdis-2016-210431
31.
ZhangZShiLPangWLiuWLiJWangHet al. Dietary fiber intake regulates intestinal microflora and inhibits ovalbumin-induced allergic airway inflammation in a mouse model. PLoS ONE (2016) 11:e0147778. 10.1371/journal.pone.0147778
32.
DesaiMSSeekatzAMKoropatkinNMKamadaNHickeyCAWolterMet al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell (2016) 167:1339–53.e21. 10.1016/j.cell.2016.10.043
33.
WuGDChenJHoffmannCBittingerKChenYYKeilbaughSAet al. Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 334:105–8. 10.1126/science.1208344
34.
WongJM. Gut microbiota and cardiometabolic outcomes: influence of dietary patterns and their associated components. Am J Clin Nutr. (2014) 100(Suppl. 1):369–77s. 10.3945/ajcn.113.071639
35.
ChoiEYJinJYChoiJIChoiISKimSJ. DHA suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages. Brit J Nutr. (2014) 111:1221–30. 10.1017/S0007114513003681
36.
DiamantiAPManuela RosadoMLaganaBD'AmelioR. Microbiota and chronic inflammatory arthritis: an interwoven link. J Transl Med. (2016) 14:233. 10.1186/s12967-016-0989-3
Summary
Keywords
diet, rheumatoid arthritis, gut microbiota, nutrition, carbohydrate, omega-3 polyunsaturated fatty acids
Citation
Masuko K (2018) A Potential Benefit of “Balanced Diet” for Rheumatoid Arthritis. Front. Med. 5:141. doi: 10.3389/fmed.2018.00141
Received
27 November 2017
Accepted
25 April 2018
Published
15 May 2018
Volume
5 - 2018
Edited by
Dimitrios Vassilopoulos, National and Kapodistrian University of Athens Medical School, Greece
Reviewed by
Ali Mobasheri, University of Surrey, United Kingdom; Theodoros Dimitroulas, Aristotle University of Thessaloniki, Greece
Updates
Copyright
© 2018 Masuko.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kayo Masuko k_msk@mac.com
This article was submitted to Rheumatology, a section of the journal Frontiers in Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.